Drug
Shr1459 Fasted IN P1
Shr1459 Fasted IN P1: highest development phase Phase 1, developed by Jiangsu Hengrui Medicine. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Jiangsu Hengrui Medicine
Trials
| Drug | Phase | Indication |
|---|---|---|
| SHR1459 fasted in P1, high-fat diet in P2 NCT04291846 | Phase 1 | Healthy Adult Subjects |
Latest
No recent events.
Follow Shr1459 Fasted IN P1 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.